SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 425 - Prospectuses and communications, business combinations:
SEC Accession No. 0001104659-18-003241
Filing Date
2018-01-22
Accepted
2018-01-22 12:10:53
Documents
3

Document Format Files

Seq Description Document Type Size
1 425 a18-3552_7425.htm 425 35059
2 GRAPHIC g35527bgi001.jpg GRAPHIC 5889
3 GRAPHIC g35527bgi002.jpg GRAPHIC 6831
  Complete submission text file 0001104659-18-003241.txt   54521
Mailing Address 167 SIDNEY STREET CAMBRIDGE MA 02139
Business Address 167 SIDNEY STREET CAMBRIDGE MA 02139 6176795500
IDERA PHARMACEUTICALS, INC. (Subject) CIK: 0000861838 (see all company filings)

IRS No.: 043072298 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 425 | Act: 34 | File No.: 001-31918 | Film No.: 18539252
SIC: 2836 Biological Products, (No Diagnostic Substances)

Mailing Address 4505 EMPEROR BOULEVARD SUITE 200 DURHAM NC 27703
Business Address 4505 EMPEROR BOULEVARD SUITE 200 DURHAM NC 27703 919-859-1302
BIOCRYST PHARMACEUTICALS INC (Filed by) CIK: 0000882796 (see all company filings)

IRS No.: 621413174 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 425
SIC: 2836 Biological Products, (No Diagnostic Substances)